BPG is committed to discovery and dissemination of knowledge
Citation
Lulic I, Lulic D, Pavicic Saric J, Bacak Kocman I, Rogic D. Personalized translational medicine: Investigating YKL-40 as early biomarker for clinical risk stratification in hepatocellular carcinoma recurrence post-liver transplantation. World J Transplant 2025; 15(2): 103036 [PMID: 40535496 DOI: 10.5500/wjt.v15.i2.103036]
Please LOGIN to submit a new comment.